Infantile Neuroaxonal Dystrophy clinical trials at UCSF

1 in progress, 0 open to eligible people

RT001 in Subjects With Infantile Neuroaxonal Dystrophy
Sorry, in progress, not accepting new patients
The purpose of this study is to evaluate the efficacy and safety of RT001 in patients with Infantile Neuroaxonal Dystrophy (INAD).
San Francisco, California and other locations

Last updated: October 2021